Biotechnology Minor

Biotechnology refers to harnessing the properties of a living organism to develop and manufacture products that benefit human life. With this minor, you will gain the basic knowledge and understanding of life science-based products, processes, and product quality to prepare you for employment opportunities in the area of biotechnology and biotech-manufacturing.

Availability
This minor is available to any Purdue University student majoring in a four-year degree baccalaureate degree program.

Requirements
22 credit hours are required to complete the minor.

Required Courses

Semester 1 / 2
BIOL 112 Fundamentals of Biology I 2
BIOL 113 Fundamentals of Biology II 2
Semester 3/4
IT 226 Biotechnology Lab I 2
IT 227 Biotechnology Lab II 2
BIOL 295E The Biology of the Living Cell 3
BIOL 241 Biology IV: Genetics and Molecular Biology 3
IPPH 522 Good Regulatory Practice 3
Semester 5
CPT 227 Bioinformatics 3
IT 342 Statistical Quality Control 3

This interdisciplinary biotechnology initiative is the result of a partnership among the Purdue Polytechnic Institute and the Colleges of Science, Agriculture and Pharmacy.

For more information, contact Prof. Kari Clase.

More information about biotechnology
The combination of biological sciences with high technology applications is predicted to provide solutions to major national problems by creating new generations of industrial biotechnology with great potential for economic impact. There are current and projected shortages of graduates with the knowledge needed in the growing biotechnology industry; our minor in biotechnology will help meet these demands. This growth has resulted in an industry with a shortage of employees familiar with and skilled in the biotechnology field; and therefore, the offering of a biotechnology minor for Purdue students.

Although the biotechnology field has existed for nearly a century, scientific advances have caused exponential growth over the past decade.

  • $26 billion increase in revenue for United States biotech industries from 1992-2001
  • $14 billion increase in private investment in biotech firms from 1992 to 2003
  • 187 biotech products manufactured in the United States in 2002; 22 products were on the market in 1993

Among the wide-range of biotech products and processes being researched and manufactured include:

  • Biomaterials for tissue engineering and reengineering blood vessels, ligaments, and skin
  • Release devices for the delivery of drugs, peptides, and proteins
  • Microbes to clean up contaminated soil and groundwater
  • Edible vaccines
  • Crops that thrive in a wide range of conditions
  • DNA-based forensic technologies that let the innocent go free and bring criminals to justice